1. Home
  2. Stocks
  3. Medico Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Medico Remedies Share Price

    Small Cap
    ₹46.5
    + 0.8 (1.75%)
    18 September, 2024 02:37 BSE: 540937 NSE: MEDICO ISIN: INE630Y01024
    Bonus Split

    Start SIP in Medico Remedies

    Start SIP

    Medico Remedies Performance

    Day Range

    • Low 45
    • High 47
    ₹ 46

    52 Week Range

    • Low 35
    • High 93
    ₹ 46
    • Open Price0
    • Previous Close46
    • Volume28745

    Medico Remedies Chart

    • Over 1 Month + 24.36%
    • Over 3 Month + 16.08%
    • Over 6 Month -41.62%
    • Over 1 Year -33.33%

    Medico Remedies Key Statistics

    P/E Ratio 45.1
    PEG Ratio 10.7
    Market Cap Cr
    Price to Book Ratio 7.4
    EPS 1
    Dividend 0
    Relative Strength Index 63.74
    Money Flow Index 67.62
    MACD Signal 1.64
    Average True Range 1.53

    Medico Remedies Investment Rating

    • Master Rating:

    • Medico Remedies has an operating revenue of Rs. 144.25 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 8% is okay, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Medico Remedies Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 314130423128
    Operating Expenses Qtr Cr 283727392925
    Operating Profit Qtr Cr 353323
    Depreciation Qtr Cr 111111
    Interest Qtr Cr 000000
    Tax Qtr Cr 111111
    Net Profit Qtr Cr 231212
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 147144
    Operating Expenses Annual Cr 132131
    Operating Profit Annual in Cr 1310
    Depreciation Cr 33
    Interest Annual Cr 11
    Tax Annual Cr 33
    Net Profit Annual Cr 87
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 8
    Cash from Investing Activity Annual Cr -7
    Cash from Financing Annual Activity Cr -2
    Net Cash Flow Annual Cr 0
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 5244
    Fixed Assets Annual Cr 2122
    Total Non Current Assets Annual Cr 2223
    Total Current Assets Annual Cr 7465
    Total Assets Annual Cr 9687
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 65
    ROE Annual % 1617
    ROCE Annual % 2324
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1010
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Medico Remedies

    Medico Remedies Technicals

    EMA & SMA

    Current Price
    ₹46.5
    + 0.8 (1.75%)
    pointer
    • Bullish Moving Average
    • ___
    • 13
    • Bearish Moving Average
    • ___
    • 3
    • 20 Day
    • ₹43.97
    • 50 Day
    • ₹42.27
    • 100 Day
    • ₹45.01
    • 200 Day
    • ₹52.34
    • 20 Day
    • ₹44.10
    • 50 Day
    • ₹40.58
    • 100 Day
    • ₹40.46
    • 200 Day
    • ₹58.63

    Medico Remedies Resistance and Support

    PIVOT
    ₹46.05
    Resistance
    First Resistance 46.95
    Second Resistance 47.40
    Third Resistance 48.30
    RSI 63.74
    MFI 67.62
    MACD Single Line 1.64
    MACD 1.60
    Support
    First Support 45.60
    Second Support 44.70
    Third Supoort 44.25

    Medico Remedies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 89,064 8,906,400 100
    Week 56,114 5,611,360 100
    1 Month 167,112 16,711,232 100
    6 Month 340,398 24,399,747 71.68

    Medico Remedies Result Highlights

    Medico Remedies Synopsis

    NSE-Medical-Diversified

    Medico Remedies belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 144.92 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 31/03/2024. Medico Remedies Ltd. is a Public Limited Listed company incorporated on 18/03/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1994PLC077187 and registration number is 077187.
    Market Cap 173
    Sales 144
    Shares in Float 2.24
    No of funds 5
    Yield
    Book Value 3.3
    U/D Vol ratio 1.8
    LTDebt / Equity 1
    Alpha 5.03
    Beta

    Medico Remedies Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 73.34%73.34%73.34%73.34%
    Foreign Portfolio Investors 0.22%0.29%1.29%1.11%
    Individual Investors 17.49%14.39%14.64%13.21%
    Others 8.95%11.98%10.73%12.34%

    Medico Remedies Management

    Name Designation
    Mr. Haresh Kapurlal Mehta Chairman & Wholetime Director
    Mr. Harshit Haresh Mehta Managing Director
    Mr. Rishit Haresh Mehta Whole Time Director
    Mr. Dayanand Shivshankar Mathapati Additional Executive Director
    Mrs. Rita Haresh Mehta Woman Non Executive Director
    Mr. Deepesh Rajesh Shah Ind. Non-Executive Director
    Mr. Ramesh Narandas Rughani Ind. Non-Executive Director
    Mr. Bharat Nathalal Rathod Ind. Non-Executive Director
    Mr. Deepak Maganlal Vekaria Ind. Non-Executive Director
    Mr. Kunal Tushar Vora Addnl.Non Exe.Independent Director

    Medico Remedies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Medico Remedies Corporate Action

    Date Purpose Remarks
    2024-08-12 Quarterly Results
    2024-05-09 Audited Results
    2024-02-12 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-10 Quarterly Results
    Date Purpose Remarks
    2021-11-17 Bonus Rs.0.00 issue of equity shares in the ratio of 3:1 of Rs.. 10/-.
    Date Purpose Remarks
    2023-03-16 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

    Medico Remedies MF Shareholding

    Name Amount(cr)

    Medico Remedies FAQs

    What is Share Price of Medico Remedies ?

    Medico Remedies share price is ₹46 As on 18 September, 2024 | 02:23

    What is the Market Cap of Medico Remedies ?

    The Market Cap of Medico Remedies is ₹385.9 Cr As on 18 September, 2024 | 02:23

    What is the P/E ratio of Medico Remedies ?

    The P/E ratio of Medico Remedies is 45.1 As on 18 September, 2024 | 02:23

    What is the PB ratio of Medico Remedies ?

    The PB ratio of Medico Remedies is 7.4 As on 18 September, 2024 | 02:23

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.